Highland Capital Management (Tennessee)’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $487K | Hold |
925
| – | – | 0.02% | 317 |
|
|
2026
Q1 | $520K | Hold |
925
| – | – | 0.03% | 303 |
|
|
2025
Q4 | $626K | Hold |
925
| – | – | 0.03% | 259 |
|
|
2025
Q3 | $591K | Hold |
925
| – | – | 0.03% | 278 |
|
|
2025
Q2 | $496K | Hold |
925
| – | – | 0.03% | 278 |
|
|
2025
Q1 | $388K | Hold |
925
| – | – | 0.02% | 290 |
|
|
2024
Q4 | $382K | Hold |
925
| – | – | 0.02% | 284 |
|
|
2024
Q3 | $467K | Hold |
925
| – | – | 0.03% | 282 |
|
|
2024
Q2 | $451K | Hold |
925
| – | – | 0.03% | 278 |
|
|
2024
Q1 | $499K | Hold |
925
| – | – | 0.03% | 280 |
|
|
2023
Q4 | $513K | Hold |
925
| – | – | 0.03% | 278 |
|
|
2023
Q3 | $404K | Hold |
925
| – | – | 0.03% | 285 |
|
|
2023
Q2 | $465K | Hold |
925
| – | – | 0.03% | 275 |
|
|
2023
Q1 | $463K | Hold |
925
| – | – | 0.03% | 233 |
|
|
2022
Q4 | $377K | Sell |
925
-10
| -1% | -$3.88K | 0.03% | 294 |
|
|
2022
Q3 | $305K | Hold |
935
| – | – | 0.02% | 285 |
|
|
2022
Q2 | $328K | Hold |
935
| – | – | 0.02% | 288 |
|
|
2022
Q1 | $512K | Hold |
935
| – | – | 0.03% | 277 |
|
|
2021
Q4 | $616K | Hold |
935
| – | – | 0.03% | 273 |
|
|
2021
Q3 | $581K | Hold |
935
| – | – | 0.04% | 275 |
|
|
2021
Q2 | $590K | Hold |
935
| – | – | 0.04% | 268 |
|
|
2021
Q1 | $458K | Sell |
935
-75
| -7% | -$37.6K | 0.03% | 284 |
|
|
2020
Q4 | $505K | Hold |
1,010
| – | – | 0.03% | 275 |
|
|
2020
Q3 | $397K | Hold |
1,010
| – | – | 0.03% | 267 |
|
|
2020
Q2 | $333K | Hold |
1,010
| – | – | 0.03% | 270 |
|
|
2020
Q1 | $245K | Hold |
1,010
| – | – | 0.02% | 280 |
|
|
2019
Q4 | $264K | Sell |
1,010
-1,000
| -50% | -$264K | 0.02% | 292 |
|
|
2019
Q3 | $547K | Buy |
2,010
+100
| +5% | +$27.8K | 0.04% | 252 |
|
|
2019
Q2 | $526K | Buy |
1,910
+550
| +40% | +$136K | 0.04% | 251 |
|
|
2019
Q1 | $304K | Hold |
1,360
| – | – | 0.02% | 285 |
|
|
2018
Q4 | $253K | Hold |
1,360
| – | – | 0.02% | 291 |
|
|
2018
Q3 | $340K | Hold |
1,360
| – | – | 0.02% | 281 |
|
|
2018
Q2 | $296K | Hold |
1,360
| – | – | 0.02% | 327 |
|
|
2018
Q1 | $260K | Hold |
1,360
| – | – | 0.02% | 321 |
|
|
2017
Q4 | $213K | Sell |
1,360
-350
| -20% | -$55.1K | 0.02% | 343 |
|
|
2017
Q3 | $266K | Hold |
1,710
| – | – | 0.02% | 328 |
|
|
2017
Q2 | $276K | Hold |
1,710
| – | – | 0.02% | 327 |
|
|
2017
Q1 | $264K | Buy |
+1,710
| New | +$236K | 0.02% | 307 |
|
Other funds holding IDXX
Highland Capital Management (Tennessee)'s IDXX Position: Q2 2026 in Review
Highland Capital Management (Tennessee) held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 925 shares worth $487K. The position accounts for 0.02% of the portfolio, ranked #317.
Highland Capital Management (Tennessee) first reported a position in IDXX in Q1 2017 and has held it in 38 quarters since. The position peaked at $626K in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Highland Capital Management (Tennessee) held 925 shares of Idexx Laboratories worth $487K as of Q2 2026.
- Highland Capital Management (Tennessee) left its Idexx Laboratories share count unchanged in Q2 2026.
- Idexx Laboratories made up 0.02% of Highland Capital Management (Tennessee)'s portfolio in Q2 2026, its #317 holding.
- Highland Capital Management (Tennessee) first reported a position in Idexx Laboratories in Q1 2017 and has held it in 38 quarters since.
- Highland Capital Management (Tennessee)'s Idexx Laboratories position peaked at $626K in Q4 2025.
- 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Highland Capital Management (Tennessee)'s 13F filing for Q2 2026, filed 21 Jul 2026.